|
ASX - By Stock
|
MSB |
Re:
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
|
|
otherperspective
|
61 |
21K |
92 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
61
|
21K
|
92
|
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast 2026: 'Itescu is unapologetic'
|
|
otherperspective
|
118 |
30K |
95 |
02/12/25 |
| 02/12/25 |
ASX - By Stock
|
118
|
30K
|
95
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Revenue Growth Highlighted in AGM Trading Update
|
|
otherperspective
|
138 |
47K |
144 |
25/11/25 |
| 25/11/25 |
ASX - By Stock
|
138
|
47K
|
144
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
92 |
20/11/25 |
| 20/11/25 |
ASX - By Stock
|
19K
|
7.2M
|
92
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appointment of Chief Financial Officer
|
|
otherperspective
|
113 |
32K |
110 |
18/11/25 |
| 18/11/25 |
ASX - By Stock
|
113
|
32K
|
110
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation
|
|
otherperspective
|
353 |
106K |
77 |
07/11/25 |
| 07/11/25 |
ASX - By Stock
|
353
|
106K
|
77
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation
|
|
otherperspective
|
353 |
106K |
117 |
06/11/25 |
| 06/11/25 |
ASX - By Stock
|
353
|
106K
|
117
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation
|
|
otherperspective
|
353 |
106K |
132 |
05/11/25 |
| 05/11/25 |
ASX - By Stock
|
353
|
106K
|
132
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
20K |
8.7M |
50 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
20K
|
8.7M
|
50
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
20K |
8.7M |
84 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
20K
|
8.7M
|
84
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Revenues Increase 66% in Second Quarter Post Launch
|
|
otherperspective
|
198 |
64K |
82 |
07/10/25 |
| 07/10/25 |
ASX - By Stock
|
198
|
64K
|
82
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Revenues Increase 66% in Second Quarter Post Launch
|
|
otherperspective
|
198 |
64K |
42 |
07/10/25 |
| 07/10/25 |
ASX - By Stock
|
198
|
64K
|
42
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Revenues Increase 66% in Second Quarter Post Launch
|
|
otherperspective
|
198 |
64K |
104 |
07/10/25 |
| 07/10/25 |
ASX - By Stock
|
198
|
64K
|
104
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
65 |
25/09/25 |
| 25/09/25 |
ASX - By Stock
|
19K
|
7.2M
|
65
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
123 |
18/09/25 |
| 18/09/25 |
ASX - By Stock
|
19K
|
7.2M
|
123
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
otherperspective
|
589 |
234K |
19 |
03/09/25 |
| 03/09/25 |
ASX - By Stock
|
589
|
234K
|
19
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
otherperspective
|
589 |
234K |
75 |
03/09/25 |
| 03/09/25 |
ASX - By Stock
|
589
|
234K
|
75
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB CEO chats with Bell Potter
|
|
otherperspective
|
33 |
16K |
117 |
17/08/25 |
| 17/08/25 |
ASX - By Stock
|
33
|
16K
|
117
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
20K |
8.7M |
107 |
11/08/25 |
| 11/08/25 |
ASX - By Stock
|
20K
|
8.7M
|
107
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
80 |
31/07/25 |
| 31/07/25 |
ASX - By Stock
|
19K
|
7.2M
|
80
|
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
otherperspective
|
212 |
100K |
43 |
24/07/25 |
| 24/07/25 |
ASX - By Stock
|
212
|
100K
|
43
|
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
otherperspective
|
212 |
100K |
109 |
21/07/25 |
| 21/07/25 |
ASX - By Stock
|
212
|
100K
|
109
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
otherperspective
|
456 |
213K |
85 |
19/07/25 |
| 19/07/25 |
ASX - By Stock
|
456
|
213K
|
85
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
otherperspective
|
456 |
213K |
56 |
18/07/25 |
| 18/07/25 |
ASX - By Stock
|
456
|
213K
|
56
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
otherperspective
|
456 |
213K |
96 |
18/07/25 |
| 18/07/25 |
ASX - By Stock
|
456
|
213K
|
96
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
otherperspective
|
3.1K |
1.3M |
112 |
18/07/25 |
| 18/07/25 |
ASX - By Stock
|
3.1K
|
1.3M
|
112
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
93 |
16/07/25 |
| 16/07/25 |
ASX - By Stock
|
19K
|
7.2M
|
93
|
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
otherperspective
|
212 |
100K |
92 |
10/07/25 |
| 10/07/25 |
ASX - By Stock
|
212
|
100K
|
92
|
|
|
ASX - By Stock
|
MSB |
Re:
Chart
|
|
otherperspective
|
628 |
251K |
43 |
09/07/25 |
| 09/07/25 |
ASX - By Stock
|
628
|
251K
|
43
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
35 |
09/07/25 |
| 09/07/25 |
ASX - By Stock
|
19K
|
7.2M
|
35
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
57 |
09/07/25 |
| 09/07/25 |
ASX - By Stock
|
19K
|
7.2M
|
57
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
73 |
08/07/25 |
| 08/07/25 |
ASX - By Stock
|
19K
|
7.2M
|
73
|
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
otherperspective
|
212 |
100K |
124 |
04/07/25 |
| 04/07/25 |
ASX - By Stock
|
212
|
100K
|
124
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
otherperspective
|
545 |
183K |
80 |
03/07/25 |
| 03/07/25 |
ASX - By Stock
|
545
|
183K
|
80
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
otherperspective
|
545 |
183K |
48 |
30/06/25 |
| 30/06/25 |
ASX - By Stock
|
545
|
183K
|
48
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
otherperspective
|
545 |
183K |
106 |
30/06/25 |
| 30/06/25 |
ASX - By Stock
|
545
|
183K
|
106
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
otherperspective
|
3.1K |
1.3M |
51 |
23/06/25 |
| 23/06/25 |
ASX - By Stock
|
3.1K
|
1.3M
|
51
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
otherperspective
|
545 |
183K |
58 |
21/06/25 |
| 21/06/25 |
ASX - By Stock
|
545
|
183K
|
58
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
otherperspective
|
15 |
7.5K |
94 |
18/06/25 |
| 18/06/25 |
ASX - By Stock
|
15
|
7.5K
|
94
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Maintains Momentum with FDA
|
|
otherperspective
|
246 |
123K |
77 |
12/06/25 |
| 12/06/25 |
ASX - By Stock
|
246
|
123K
|
77
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
otherperspective
|
3.1K |
1.3M |
47 |
12/06/25 |
| 12/06/25 |
ASX - By Stock
|
3.1K
|
1.3M
|
47
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
otherperspective
|
3.1K |
1.3M |
111 |
05/06/25 |
| 05/06/25 |
ASX - By Stock
|
3.1K
|
1.3M
|
111
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
otherperspective
|
3.1K |
1.3M |
60 |
02/06/25 |
| 02/06/25 |
ASX - By Stock
|
3.1K
|
1.3M
|
60
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
98 |
30/05/25 |
| 30/05/25 |
ASX - By Stock
|
19K
|
7.2M
|
98
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
89 |
27/05/25 |
| 27/05/25 |
ASX - By Stock
|
19K
|
7.2M
|
89
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
51 |
23/05/25 |
| 23/05/25 |
ASX - By Stock
|
19K
|
7.2M
|
51
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
95 |
22/05/25 |
| 22/05/25 |
ASX - By Stock
|
19K
|
7.2M
|
95
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
|
|
otherperspective
|
272 |
114K |
91 |
19/05/25 |
| 19/05/25 |
ASX - By Stock
|
272
|
114K
|
91
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
|
|
otherperspective
|
272 |
114K |
26 |
16/05/25 |
| 16/05/25 |
ASX - By Stock
|
272
|
114K
|
26
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
19K |
7.2M |
56 |
12/05/25 |
| 12/05/25 |
ASX - By Stock
|
19K
|
7.2M
|
56
|
|